Busulfan analysis with quantitative UPLC-MS/MS for clinical research

Achieve rapid analysis and increased sensitivity

Traditional analytical methods encounter challenges when quantifying busulfan, an antineoplastic cancer therapy, due to its bioavailability. UPLC-MS/MS analysis with the ACQUITY UPLC I-Class PLUS and Xevo TQD Mass Spectrometer provides clinical research laboratories with highly selective and accurate data, as well as and rapid analysis and increased sensitivity.

Request Pricing
  • Overview
  • Related
  • Application Notes